Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis

Glycemic variability (GV) has been an emerging target for preventing complications related to type 2 diabetes. For reducing GV, DPP-IV inhibitors have shown effectiveness compared to other oral anti-hyperglycemic drugs (OADs), but systematic evaluation has yet to be existed. A systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Subin, Lee, Heeyoung, Kim, Yoonhye, Kim, EunYoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746852/
https://www.ncbi.nlm.nih.gov/pubmed/31527625
http://dx.doi.org/10.1038/s41598-019-49803-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746852/
https://www.ncbi.nlm.nih.gov/pubmed/31527625
http://dx.doi.org/10.1038/s41598-019-49803-9

Ejemplares similares